Latest News
05/21/13 - DZNE Researcher Elected to the European Science Organization EMBO
The European Molecular Biology Organization (EMBO) has elected biochemist Frank Bradke of the German Center for Neurodegenerative Diseases (DZNE) as one of its new members. According to the EMBO, 52 scientists joined the ...
05/16/13 - DZNE and Charité work together: with joined forces against neurodegenerative diseases
The DZNE and Charité - Universitätsmedizin Berlin are internationally leading institutions for research in the field of neurodegenerative diseases. Now, both have signed a cooperation agreement to seal their close scientific ...
05/10/13 - Experience Leads to the Growth of New Brain Cells
How do organisms evolve into individuals that are distinguished from others by their own personal brain structure and behavior? Scientists in Dresden, Berlin, Münster, and Saarbrücken have now taken a decisive step towards ...
05/06/13 - Ground breaking ceremony: Ministers Schulze and Wanka kick off construction of the new DZNE building 110 million Euro for neuroscience
A traditional ground breaking ceremony signaled the start of construction work on the new facility for the German Center for Neurodegenerative Diseases (DZNE) on the Venusberg in Bonn, on the grounds of the university clinic. ...
03/27/13 - Transmission routes of spreading protein particles
In diseases like Alzheimer’s and Parkinson’s endogenous proteins accumulate in the brain, eventually leading to the death of nerve cells. These deposits, which consist of abnormally formed proteins, are supposed to migrate ...
03/01/13 - Misplaced molecules: new insights into the causes of dementia
A team of German and Belgian researchers has succeeded in gaining new insights into the causes of certain movement disorders and forms of dementia. Scientists including Bettina Schmid and Christian Haass from the DZNE in Munich ...
02/26/13 - Researchers find controlling element of Huntington’s disease
A three molecule complex may be a target for treating Huntington’s disease, a genetic disorder affecting the brain. This finding by an international research team including scientists from the German Center for Neurodegenerative ...
02/20/13 - Researchers decipher modus operandi of potential Alzheimer’s drug
The chemical compound known as “methylene blue” is a potential candidate for treating Alzheimer’s, as it prevents the harmful clumping of so-called tau proteins typically associated with this disease. However, until now it was ...
02/07/13 - Translation error tracked in the brain of dementia patients
Scientists identify enigmatic aggregates linked to neurodegenerative diseases
01/17/13 - Setting New Standards for Dementia and Healthcare Research
From January 2013: New site speaker at DZNE Witten
01/11/13 - Ulm: New Research Centres for Diseases of the Nervous System
Federal Minister Schavan inaugurates new DZNE and University of Ulm institutes
Working together against Alzheimer‘s, Parkinson‘s and dementia
Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases
Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
Joint Press Release of the German Center for Neurodegenerative Diseases and the Max Planck Research Unit for Enzymology of Protein Folding
Prof. Pierluigi Nicotera Receives the Honorary Citizenship and the Key to the City of New Orleans
DZNE Scientific Director honored
